Evidence map›Paper›PMID 37173355›Full record

Observational studyScientific reports2023

Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19.

Stefan Malesevic, Noriane A Sievi, Patrick Baumgartner, Katharina Roser, Grit Sommer, Dörthe Schmidt, Florence Vallelian, Ilijas Jelcic, Christian F Clarenbach, Malcolm Kohler

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04793269 (Long COVID Syndrom), which is not on this map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04793269 active not recruitingnot on this map

Long COVID Syndrom: Charakterisierung Eines Neuen Krankheitsbildes

TypeobservationalSponsorChristian ClarenbachRan2021 to 2025Enrolled200ConditionsLong COVID SyndromeArmsNo intervention
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Impact of long COVID on health-related quality-of-life among Japanese adults: findings of CARE Japan study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stefan MalesevicFaculty of Medicine, University of Zurich, Zurich, Switzerland. stefan.malesevic@usz.ch.
Noriane A SieviDepartment of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland.
Patrick BaumgartnerFaculty of Medicine, University of Zurich, Zurich, Switzerland.
Katharina RoserDepartment of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
Grit SommerDivision of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Dörthe SchmidtDepartment of Cardiology, University Hospital Zurich, Zurich, Switzerland.
Florence VallelianDepartment of Internal Medicine, University Hospital Zurich, Zurich, Switzerland.
Ilijas JelcicDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
Christian F ClarenbachFaculty of Medicine, University of Zurich, Zurich, Switzerland.
Malcolm KohlerDepartment of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A growing number of patients with SARS-CoV-2 infections experience long-lasting symptoms. Even patients who suffered from a mild acute infection show a variety of persisting and debilitating neurocognitive, respiratory, or cardiac symptoms (Long-Covid syndrome), consequently leading to limitations in everyday life. Because data on health-related quality of life (HRQoL) is scarce, we aimed to characterize the impact of Long-Covid symptoms after a mild or moderate acute infection on HRQoL. In this observational study, outpatients seeking counseling in the interdisciplinary Post-Covid consultation of the University Hospital Zurich with symptoms persisting for more than 4 weeks were included. Patients who received an alternative diagnosis or suffered from a severe acute Covid-19 infection were excluded. St. George's Respiratory Questionnaire (SGRQ), Euroquol-5D-5L (EQ-5D-5L), and the Short form 36 (SF-36) were distributed to assess HRQoL. 112 patients were included, 86 (76.8%) were female, median (IQR) age was 43 (32.0, 52.5) years with 126 (91, 180) days of symptoms. Patients suffered frequently from fatigue (81%), concentration difficulties (60%), and dyspnea (60%). Patients mostly stated impairment in performing usual activities and having pain/discomfort or anxiety out of the EQ-5D-5L. EQ index value and SGRQ activity score component were significantly lower in females. SF-36 scores showed remarkably lower scores in the physical health domain compared to the Swiss general population before and during the COVID-19 pandemic. Long-Covid syndrome has a substantial impact on HRQoL. Long-term surveillance of patients must provide clarity on the duration of impairments in physical and mental health.Trial registration: The study is registered on www.ClinicalTrials.gov , NCT04793269.

Indexed as

COVID-19Quality of LifeFemaleHumansMalePandemicsPost-Acute COVID-19 SyndromeSARS-CoV-2Surveys and Questionnaires

Identifiers

PMID37173355
PMCPMC10175927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.